T
BIO icon

TOBAM’s Bio-Rad Laboratories Class A BIO Stock Holding History

TOBAM’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-150
Closed -$57K – 377
2023
Q2 		$57K Buy
+150
New +$61K ﹤0.01% 349
2023
Q1 		– Sell
-72
Closed -$30K – 368
2022
Q4 		$30K Sell
72
-26
-27% -$10.5K ﹤0.01% 380
2022
Q3 		$41K Hold
98
– – ﹤0.01% 378
2022
Q2 		$49K Hold
98
– – ﹤0.01% 381
2022
Q1 		$55K Buy
98
+26
+36% +$15.7K ﹤0.01% 383
2021
Q4 		$54K Hold
72
– – ﹤0.01% 341
2021
Q3 		$54K Hold
72
– – ﹤0.01% 347
2021
Q2 		$46K Hold
72
– – ﹤0.01% 352
2021
Q1 		$41K Hold
72
– – ﹤0.01% 365
2020
Q4 		$42K Hold
72
– – ﹤0.01% 352
2020
Q3 		$37K Buy
+72
New +$36.5K ﹤0.01% 339

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

TOBAM's BIO Position: Q3 2023 in Review

TOBAM sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2023, closing a stake of 150 shares — an estimated $57K sold.

TOBAM first reported a position in BIO in Q3 2020 and held it in 11 quarters. The position peaked at $57K in Q2 2023. 468 funds tracked by Wall St. Rank hold BIO as of Q3 2023.

  • TOBAM reported no remaining Bio-Rad Laboratories Class A position as of Q3 2023 after selling out during the quarter.
  • TOBAM sold 150 Bio-Rad Laboratories Class A shares in Q3 2023, an estimated $57K.
  • TOBAM first reported a position in Bio-Rad Laboratories Class A in Q3 2020 and held it in 11 quarters.
  • TOBAM's Bio-Rad Laboratories Class A position peaked at $57K in Q2 2023.
  • 468 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2023.

Based on TOBAM's 13F filing for Q3 2023, filed 31 Oct 2023.